Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro

The ongoing COVID-19 pandemic has caused over six million deaths and huge economic burdens worldwide. Antivirals against its causative agent, SARS-CoV-2, are in urgent demand. Previously, we reported that heterocylic compounds, i.e., chloroquine (CQ) and hydroxychloroquine (HCQ), are potent in inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xi, Burdzhiev, Nikola T., Hu, Hengrui, Li, Yufeng, Li, Jiang, Lozanova, Vesela V., Kandinska, Meglena I., Wang, Manli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965753/
https://www.ncbi.nlm.nih.gov/pubmed/36851716
http://dx.doi.org/10.3390/v15020502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965753/
https://www.ncbi.nlm.nih.gov/pubmed/36851716
http://dx.doi.org/10.3390/v15020502

Ejemplares similares